1. Home
  2. AVIR vs AREN Comparison

AVIR vs AREN Comparison

Compare AVIR & AREN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVIR
  • AREN
  • Stock Information
  • Founded
  • AVIR 2012
  • AREN 2016
  • Country
  • AVIR United States
  • AREN United States
  • Employees
  • AVIR N/A
  • AREN N/A
  • Industry
  • AVIR Medicinal Chemicals and Botanical Products
  • AREN Medical/Dental Instruments
  • Sector
  • AVIR Health Care
  • AREN Health Care
  • Exchange
  • AVIR Nasdaq
  • AREN Nasdaq
  • Market Cap
  • AVIR 290.4M
  • AREN 233.1M
  • IPO Year
  • AVIR 2020
  • AREN N/A
  • Fundamental
  • Price
  • AVIR $3.27
  • AREN $5.61
  • Analyst Decision
  • AVIR Hold
  • AREN Strong Buy
  • Analyst Count
  • AVIR 1
  • AREN 1
  • Target Price
  • AVIR $6.00
  • AREN $12.00
  • AVG Volume (30 Days)
  • AVIR 453.6K
  • AREN 214.5K
  • Earning Date
  • AVIR 11-07-2025
  • AREN 11-13-2025
  • Dividend Yield
  • AVIR N/A
  • AREN N/A
  • EPS Growth
  • AVIR N/A
  • AREN N/A
  • EPS
  • AVIR N/A
  • AREN 2.74
  • Revenue
  • AVIR N/A
  • AREN $146,610,000.00
  • Revenue This Year
  • AVIR N/A
  • AREN $29.48
  • Revenue Next Year
  • AVIR N/A
  • AREN $11.72
  • P/E Ratio
  • AVIR N/A
  • AREN $8.90
  • Revenue Growth
  • AVIR N/A
  • AREN 6.81
  • 52 Week Low
  • AVIR $2.46
  • AREN $0.56
  • 52 Week High
  • AVIR $4.02
  • AREN $10.05
  • Technical
  • Relative Strength Index (RSI)
  • AVIR 57.88
  • AREN N/A
  • Support Level
  • AVIR $3.15
  • AREN N/A
  • Resistance Level
  • AVIR $3.34
  • AREN N/A
  • Average True Range (ATR)
  • AVIR 0.10
  • AREN 0.00
  • MACD
  • AVIR 0.02
  • AREN 0.00
  • Stochastic Oscillator
  • AVIR 79.37
  • AREN 0.00

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

Share on Social Networks: